Abstract
We report a patient with bone hydatid disease that was refractory to both long-term daily treatment with albendazole, combined with cimetidine or administered as monotherapy ( approximately 15 years) and a relatively short course of nitazoxanide combined with albendazole (3 months). Despite continuous daily medical treatment, bone invasion and destruction proceeded. His pain and disability progressively increased.
MeSH terms
-
Adult
-
Albendazole / administration & dosage
-
Albendazole / therapeutic use
-
Anthelmintics / administration & dosage
-
Anthelmintics / therapeutic use*
-
Bone Diseases / drug therapy*
-
Bone Diseases / parasitology
-
Bone Diseases / pathology
-
Cimetidine / administration & dosage
-
Cimetidine / therapeutic use
-
Drug Resistance*
-
Echinococcosis / complications
-
Echinococcosis / drug therapy*
-
Echinococcosis / pathology
-
Histamine H2 Antagonists / administration & dosage
-
Histamine H2 Antagonists / therapeutic use
-
Humans
-
Lumbar Vertebrae / parasitology
-
Lumbar Vertebrae / pathology
-
Lumbar Vertebrae / surgery
-
Male
-
Nitro Compounds
-
Thiazoles / administration & dosage
-
Thiazoles / therapeutic use*
Substances
-
Anthelmintics
-
Histamine H2 Antagonists
-
Nitro Compounds
-
Thiazoles
-
Cimetidine
-
Albendazole
-
nitazoxanide